A Randomized Phase 3 Trial of Paclitaxel (P) plus Carboplatin (C) Versus Paclitaxel plus Ifosfamide (I) in Chemotherapy-Naive Patients with Stage I-Iv, Persistent or Recurrent Carcinosarcoma of the Uterus or Ovary: An Nrg Oncology Trial.
AuthID
P-00V-TBB
P-00V-TBB